On Monday, Pacific Biosciences of California Inc (NASDAQ: PACB) opened lower -1.57% from the last session, before settling in for the closing price of $1.60. Price fluctuations for PACB have ranged from $1.16 to $10.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 24.48%. Company’s average yearly earnings per share was noted -12.86% at the time writing. With a float of $262.20 million, this company’s outstanding shares have now reached $267.74 million.
Let’s determine the extent of company efficiency that accounts for 796 employees. In terms of profitability, gross margin is 18.12%, operating margin of -215.33%, and the pretax margin is -228.11%.
Pacific Biosciences of California Inc (PACB) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Pacific Biosciences of California Inc is 4.26%, while institutional ownership is 81.66%. The most recent insider transaction that took place on Sep 30 ’24, was worth 34,065. In this transaction an insider of this company sold 19,782 shares at a rate of $1.72, taking the stock ownership to the 695,654 shares. Before that another transaction happened on Sep 30 ’24, when Company’s Officer proposed sale 19,782 for $1.72, making the entire transaction worth $34,061.
Pacific Biosciences of California Inc (PACB) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.27 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.28) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -12.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.00% during the next five years compared to -9.76% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Check out the current performance indicators for Pacific Biosciences of California Inc (PACB). In the past quarter, the stock posted a quick ratio of 8.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Looking closely at Pacific Biosciences of California Inc (NASDAQ: PACB), its last 5-days average volume was 14.56 million, which is a jump from its year-to-date volume of 9.66 million. As of the previous 9 days, the stock’s Stochastic %D was 2.59%. Additionally, its Average True Range was 0.26.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 26.28%, which indicates a significant increase from 0.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 118.47% in the past 14 days, which was lower than the 123.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9140, while its 200-day Moving Average is $2.4460. However, in the short run, Pacific Biosciences of California Inc’s stock first resistance to watch stands at $1.6500. Second resistance stands at $1.7300. The third major resistance level sits at $1.7700. If the price goes on to break the first support level at $1.5300, it is likely to go to the next support level at $1.4900. Now, if the price goes above the second support level, the third support stands at $1.4100.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
There are currently 273,864K shares outstanding in the company with a market cap of 369.70 million. Presently, the company’s annual sales total 200,520 K according to its annual income of -306,740 K. Last quarter, the company’s sales amounted to 39,970 K and its income totaled -60,730 K.
